Search Results

CENTER TO FOCUS ON IMMUNE SYSTEMS.

• Authors : Mortland, Shannon

Subjects: *HEALTH facilities; CLINICAL immunology; IMMUNOLOGIC diseasesRJF International Corp.FASENMYER, Richard J.

• Source: Crain's Cleveland Business. 12/12/2005, Vol. 26 Issue 50, p1-1. 1/9p.

Record details

Anti-CTLA-4 antibody and GM-CSF show promise for hormone refractory prostate cancer.

• Authors : Weiner, Louis¹

Subjects: *IMMUNOTHERAPY; *CLINICAL immunology; *THERAPEUTICS

• Source: Hem/Onc Today. 5/10/2008, Vol. 9 Issue 8, p22-22. 1/2p.

Record details

Improving Vitiligo Repigmentation With Emerging Targeted Therapies.

Subjects: *VITILIGO; *PIGMENTATION disorders; *CLINICAL immunology

• Source: HCPLive. 2022 Supplement, p1-17. 17p.

Record details

Recommendations and Reports Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

• Authors : Liang, Jennifer L.; Tiwari, Tejpratap; Moro, Pedro

Subjects: DIPHTHERIA; WHOOPING cough; BACTERIAL vaccinesUNITED States

• Source: MMWR Recommendations & Reports. 4/27/2018, Vol. 67 Issue 2, p1-42. 42p. 6 Charts, 4 Graphs.

Record details

PLURISTEM GETS DSMB APPROVAL FOR PLX-PAD FINAL DOSE LEVEL.

Subjects: CELLULAR therapy; PLACENTAL extracts; CLINICAL trialsISRAEL; EUROPEPLURI Inc.

• Source: Biotech Business. Apr2010, Vol. 23 Issue 4, p6-7. 2p.

Record details

Review of the 65th Conference on Mass Spectrometry and Allied Topics.

• Authors : Delonas, Cindy

Subjects: *MASS spectrometry; *IMMUNOTHERAPY; *CLINICAL immunologyMURRAY, Kermit K.; HUNT, Donald F.

• Source: Spectroscopy. Jul2017 Supplement Current Trends in Mass Spectrometry, p32-33. 2p.

Record details

PLURISTEM GETS INTERIM TOP-LINE RESULTS FROM PLX-PAD TRIALS.

Subjects: CLINICAL trials; PLACENTA; CELLULAR therapyHAIFA (Israel); ISRAELPLURI Inc.

• Source: Worldwide Biotech. Jun2010, Vol. 22 Issue 6, p3-5. 3p.

Record details

NEW DATA FROM CALDOLOR BURN PATIENT STUDY REPORTED.

Subjects: IBUPROFEN; INJECTIONS; TREATMENT for burns & scaldsCUMBERLAND Pharmaceuticals Inc. CUMBERLAND Pharmaceuticals Inc. CUMBERLAND Pharmaceuticals Inc. CPIX; AMERICAN Burn Association

• Source: Biotech Business. Apr2010, Vol. 23 Issue 4, p5-6. 2p.

Record details

The growth of immuno-oncology: active, passive and hybrid treatments in to 2020.

Subjects: CANCER treatment; IMMUNOTHERAPY; IMMUNE system

• Source: Manufacturing Chemist. Nov2017, Vol. 88 Issue 11, p18-20. 3p.

Record details

AGENCY A-Z.

Subjects: *BUSINESS planning; *BUSINESS development; *CHIEF operating officers

• Source: Medical Marketing & Media. Jul2019, Vol. 54 Issue 7, p192-241. 50p.

Record details